Astria Therapeutics, Inc. (ATXS) Financials
Stock symbol ATXS is outdated, potentially delisted? Maybe it is available on other exchange?
ATXS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2025 | 271.9 million | 38.6 million |
| June 30, 2025 | 281.9 million | 21.4 million |
| March 31, 2025 | 310.4 million | 21.1 million |
| Dec. 31, 2024 | 342.4 million | 23.1 million |
ATXS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2025 | -32.3 million | 4.3 million |
| June 30, 2025 | -36.6 million | 4.4 million |
| March 31, 2025 | -34.0 million | 3.8 million |
| Dec. 31, 2024 | -17.4 million | 3.4 million |
ATXS Net Income
No data available :(
ATXS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2025 | 227.7 million | 3.1 million | 4.5 million |
| June 30, 2025 | 259.2 million | 3.4 million | 4.8 million |
| March 31, 2025 | 295.1 million | 3.7 million | 5.1 million |
| Dec. 31, 2024 | 328.1 million | 4.0 million | 5.4 million |
ATXS Shares Outstanding
ATXS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2025 | 32.3 million | 24.1 million | 10.7 million | - |
| June 30, 2025 | 590000 | 25.9 million | 9.9 million | - |
| March 31, 2025 | - | 27.8 million | 9.2 million | - |
| Dec. 31, 2024 | - | 20.2 million | 9.7 million | 400000 |
ATXS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2025 | 706000 | - |
| June 30, 2025 | - | - |
| March 31, 2025 | - | - |
| Dec. 31, 2024 | - | - |
ATXS
Price: $12.58
52 week price:
Earnings Per Share: -2.14 USD
P/E Ratio: -5.99
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 121600
Market Capitalization: 731.8 million